Pulmonary Function Testing for Neonatal Respiratory Disorders
(PUFFOR Trial)
Trial Summary
The trial information does not specify whether participants need to stop taking their current medications.
Research shows that techniques like impulse oscillometry, which are part of the treatment, are effective in measuring lung function in children with conditions like asthma and cystic fibrosis. These methods are non-invasive, require minimal cooperation, and are sensitive in detecting changes in small airways, making them suitable for young children and potentially effective for neonatal respiratory disorders.
12345Pulmonary function testing using oscillometry, which includes techniques like forced oscillation and impulse oscillometry, is generally considered safe for humans. It is non-invasive, requires minimal patient cooperation, and is suitable for young children and those unable to perform traditional lung function tests.
12467Non-invasive forced airway oscillometry is unique because it requires minimal patient cooperation and is more sensitive in detecting changes in small airways compared to traditional pulmonary function tests. This makes it particularly useful for infants who cannot perform standard tests due to their age or condition.
1891011Eligibility Criteria
This trial is for infants born at or after 22 weeks of gestation who are off ventilators for at least 12 hours. It's open to those whose parents or guardians consent, but not to babies with terminal illnesses, neuromuscular conditions affecting breathing, major malformations, or if there's a decision to limit support.Inclusion Criteria
Exclusion Criteria
Participant Groups
Non-invasive forced airway oscillometry is already approved in European Union, United States, Canada for the following indications:
- Assessment of lung function in infants and adults
- Diagnosis of respiratory diseases such as asthma and COPD
- Assessment of lung function in infants and adults
- Monitoring of respiratory mechanics during mechanical ventilation and sleep
- Assessment of lung function in preterm infants
- Diagnosis of respiratory diseases such as bronchopulmonary dysplasia